Aptamers Market Size Worth $ 16.33 Billion By 2032 | CAGR: 24.10%

Aptamers Market Size Worth $ 16.33 Billion By 2032 | CAGR: 24.10%

The global aptamers market size is expected to reach USD 16.33 billion by 2032, according to a new study by Polaris Market Research. The report “Aptamers Market Share, Size, Trends, Industry Analysis Report, By Type (Nucleic Acid, and Peptide); By Application (Diagnostics, Therapeutics, Research & Developments, and Others); By Region, And Segment Forecasts, 2024 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Versatility of aptamers and their potential applications in various industries such as healthcare, biotechnology, and diagnostics have attracted the attention of many companies. Moreover, the availability of customized aptamers for specific targets has expanded the applications of aptamers beyond their traditional use in research and diagnostics. This has led to the development of new aptamer-based products, including therapeutics and biosensors, which are expected to further drive the growth of the aptamers market.

The SELEX technology has been used to develop aptamers that can bind to specific biomarkers related to SARS-CoV-2 and COVID-19, allowing for the development of diagnostic kits and assays. These aptamer-based diagnostic tools can provide high sensitivity and specificity in detecting the virus and related biomarkers, which can aid in disease diagnosis and monitoring. As a result, the introduction of such diagnostic kits and assays in the market is expected to drive the growth of the market.

In December 2021, Achiko AG's Aptamex, a COVID-19 diagnostic kit, received approval from the health ministry of Indonesia. Aptamex is a 2nd generation kit developed using DNA aptamer technology, which is cost-effective, chemically synthesized, diagnostic kit in the pharmaceuticals.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/aptamers-market/request-for-sample

Market growth is further supported by various regulatory agencies such as the U.S. FDA, Health Canada, EMA, COFEPRIS, MHRA, & CDSCO, which have taken initiatives to support the research and development in this field. For example, in March 2020, the U.S. FDA granted Fast Track designation to IVERIC Bio’s Zimura for the treatment of patients with geographic atrophy (GA) secondary to AMD. It is a pegylated RNA aptamer, which is synthesized & administered by the intra-vitreal injection. It works by the inhibition of factor C5, considered responsible for onset of AMD.

Aptamers Market Report Highlights

  • Nucleic acid segment dominated the market, owing to rapid development in the diagnostics, therapeutics, and advancements in the biomarker discovery
  • R&D segment accounted for the larger market share, as there is a strong interest in aptamer manufacturing companies, and favorable government initiatives
  • Diagnostic segment recorded fastest growth rate, owing to rising need for aptamer based diagnostic kits for the early disease diagnosis
  • North America garnered the largest share, owing to the presence of companies engaged in the development of aptamers, and strong industry academia collaboration for scientific breakthroughs
  • Asia Pacific is projected to register a higher growth rate, owing to the presence of large patient pool, huge untapped population, and favorable government policies for research.
  • The global players include Base Pair Biotechnologies, SomaLogic, Aptadel Therapeutics, Aptamer Group, Noxxon Pharma, Aptagen, TriLink Biotechnologies, Altermune, Vivonics, and AM Biotechnologies.

Polaris Market Research has segmented the aptamers market report based on type, application, and region:

Aptamers, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Nucleic Acid Aptamer
  • Peptide Aptamer

Aptamers, Application Outlook (Revenue - USD Billion, 2019 - 2032)

  • Diagnostics
  • Therapeutics
  • Research and Development
  • Others

Aptamers, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
    • U.S.
    • Canada
    • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
    • Netherlands
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Indonesia
    • Malaysia
  • Latin America
    • Argentina
    • Brazil
    • Mexico
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Aptamers Market Report Scope

Report Attributes


Market size value in 2024

USD 2.9 billion

Revenue forecast in 2032

USD 16.33 billion


24.10% from 2024 – 2032

Base year


Historical data

2019 – 2022

Forecast period

2024 – 2032

Quantitative units

Revenue in USD million/billion and CAGR from 2024 to 2032

Segments covered

By Type, By Application, By Region

Regional scope

North America, Europe, Asia Pacific, Latin America; Middle East & Africa

Key companies

Base Pair Biotechnologies, SomaLogic, Aptadel Therapeutics, Aptamer Group, Noxxon Pharma, Aptagen, TriLink Biotechnologies, Altermune, Vivonics, and AM Biotechnologies.

For Specific Research Requirements

Request for Customized Report